A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in JCO Precision Oncology in August.
Researchers at Duke Cancer Institute have tracked the missing T-cells in glioblastoma patients. They found them in abundance in the bone marrow, locked away and unable to function because of a process the brain stimulates in response to glioblastoma, to other tumors that metastasize in the brain and even to injury.
Researchers at the Johns Hopkins Bloomberg—Kimmel Institute for Cancer Immunotherapy developed a new way to use bioinformatics as a gathering tool to determine how a patient's immune system responds to immunotherapy and recognizes its own tumor.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University received the highest rating possible from the NCI, an overall “exceptional,” on the competitive renewal of its Cancer Center Support Grant.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been awarded a new, five-year $11.5 million Specialized Program of Research Excellence grant to advance translational research and improve outcomes for patients with brain cancer.
NCI has awarded the University of Michigan Rogel Cancer Center a grant worth $33.4 million over five years. At the same time, the center's designation as a Comprehensive Cancer Center was renewed.
Rutgers Cancer Institute of New Jersey has renewed its Comprehensive Cancer Center designation.
Bernard Fisher, University of Pittsburgh Distinguished Service Professor of Surgery recently celebrated 100thth birthday.
Agios Pharmaceuticals Inc. announced that effective Feb. 1, 2019, David Schenkein will transition to the role of executive chairman of the board of directors and serve as a member of the board's Science & Technology Committee, after a decade-long tenure as CEO. Jacqualyn (“Jackie”) Fouse, Ph.D., a member of the company's board, has been named as Agios' next CEO.
Ruth McCorkle was named an American Academy of Nursing Living Legend. The Living Legend designation is AAN's highest honor and was awarded to seven nursing professionals for 2018. The Academy will honor its Living Legend designees at its annual policy conference in Washington, DC, on Nov. 1.
